Athula Herath

Athula Herath leads the Real World Evidence Epidemiology group globally within the Real World Evidence function of the Global Medical Affairs of Novartis Pharmaceuticals. Having completed a PhD in computational statistics, Athula has been an academic for decade and moved to pharma industry over 20 years ago and developed novel analytic capabilities for various premiere pharmaceutical companies during the period. Over the past six years, Athula has pioneered a new coordinate system for landscaping disease epidemiology for total evidence synthesis of chronic diseases with complex and protracted comorbidities using novel machine learning methodology.